BioArctic AB (publ)

BIOA-B.ST · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

324 SEK (≈ 33.49 USD)

Margin of Safety

+4.5 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL BioArctic AB is a Swedish biotech company that addresses neurodegenerative diseases and generates revenues primarily through milestone and royalty payments from partnerships with global pharmaceutical companies for its clinically validated drug candidates.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.